TALS vs. CRGX, CABA, RGNX, CGEM, IMTX, RLAY, BCRX, HLVX, KYTX, and PRME
Should you be buying Talaris Therapeutics stock or one of its competitors? The main competitors of Talaris Therapeutics include CARGO Therapeutics (CRGX), Cabaletta Bio (CABA), REGENXBIO (RGNX), Cullinan Oncology (CGEM), Immatics (IMTX), Relay Therapeutics (RLAY), BioCryst Pharmaceuticals (BCRX), HilleVax (HLVX), Kyverna Therapeutics (KYTX), and Prime Medicine (PRME). These companies are all part of the "biological products, except diagnostic" industry.
CARGO Therapeutics (NASDAQ:CRGX) and Talaris Therapeutics (NASDAQ:TALS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment, valuation and community ranking.
CARGO Therapeutics presently has a consensus price target of $29.67, indicating a potential upside of 58.22%. Given Talaris Therapeutics' higher possible upside, equities research analysts plainly believe CARGO Therapeutics is more favorable than Talaris Therapeutics.
Talaris Therapeutics received 8 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 48.15% of users gave Talaris Therapeutics an outperform vote.
Talaris Therapeutics' return on equity of 0.00% beat CARGO Therapeutics' return on equity.
93.2% of CARGO Therapeutics shares are held by institutional investors. Comparatively, 67.6% of Talaris Therapeutics shares are held by institutional investors. 16.5% of Talaris Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, CARGO Therapeutics had 2 more articles in the media than Talaris Therapeutics. MarketBeat recorded 2 mentions for CARGO Therapeutics and 0 mentions for Talaris Therapeutics. Talaris Therapeutics' average media sentiment score of 0.33 beat CARGO Therapeutics' score of 0.00 indicating that CARGO Therapeutics is being referred to more favorably in the media.
Summary
CARGO Therapeutics beats Talaris Therapeutics on 8 of the 11 factors compared between the two stocks.
Get Talaris Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for TALS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TALS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Talaris Therapeutics Competitors List
Related Companies and Tools
